BPC-157 and GHK-Cu in Wound Healing and Tissue Repair: A Review of Clinical Efficacy and Safety
DOI:
https://doi.org/10.12775/QS.2026.54.70818Keywords
BPC-157, GHK-Cu, wound healing, tissue repair, peptide therapy, regenerative medicine, angiogenesis, collagen synthesis, clinical safety, sports medicineAbstract
Background: BPC-157 and GHK-Cu are synthetic peptides with potential in tissue repair, influencing molecular mechanisms in healing, angiogenesis and inflammation.
Objective: This review synthesizes preclinical and clinical research on BPC-157 and GHK-Cu efficacy and safety in wound healing and tissue repair, examining mechanistic pathways and translational potential in clinical and sports medicine.
Methods: Literature searches of PubMed, Embase and Cochrane Library included studies on wound healing, tissue regeneration, safety and clinical uses of BPC-157 and GHK-Cu without publication date restrictions.
Results: Preclinical studies show BPC-157 promotes skin, tendon, muscle and bone healing via specific signaling pathways and growth factor upregulation. GHK-Cu enhances collagen/elastin synthesis, angiogenesis and fibroblast migration. Limited human trials evaluated BPC-157 for knee pain and IV safety, while GHK-Cu showed promise in skin quality trials. Both appear safe but lack comprehensive RCTs.
Conclusion: BPC-157 and GHK-Cu show therapeutic potential in wound healing, though evidence is largely preclinical. Extensive human trials are needed to establish clinical efficacy. This review provides groundwork for future research and highlights safety for sports medicine practitioners.
References
1. Nussbaum SR, Carter MJ, Fife CE, DaVanzo JE, Haught R, Nusgart M, et al. An economic evaluation of the impact, cost, and Medicare policy implications of chronic nonhealing wounds. Value Health. 2018;21(1):27-32. doi:10.1016/j.jval.2017.07.007
2. Martinengo L, Olsson M, Bajpai R, Soljak M, Uber Z, Schmidtchen A, et al. Prevalence of chronic wounds in the general population: systematic review and meta-analysis of observational studies. Ann Epidemiol. 2019;29:8-15. doi:10.1016/j.annepidem.2018.10.005
3. Rodrigues M, Kosaric N, Bonham CA, Gurtner GC. Wound healing: a cellular perspective. Physiol Rev. 2019;99(1):665-706. doi:10.1152/physrev.00067.2017
4. Jóźwiak M, Bauer M, Kamysz W, Kleczkowska P. Multifunctionality and possible medical application of the BPC 157 peptide — literature and patent review. Pharmaceuticals. 2025;18(2):185. doi:10.3390/ph18020185
5. Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, et al. Stable gastric pentadecapeptide BPC 157 and wound healing. Front Pharmacol. 2021;12:627533. doi:10.3389/fphar.2021.627533
6. Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, et al. The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides
Life Sci. 1994;54(5):PL63-68. doi:10.1016/0024-3205(94)00796-9
7. Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. 2025 Jul 31:15563316251355551. doi: 10.1177/15563316251355551
8. McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med. 2025 Dec;18(12):611-619. doi: 10.1007/s12178-025-09990-7
9. DeFoor MT, Dekker TJ. Injectable therapeutic peptides — an adjunct to regenerative medicine and sports performance? Arthroscopy. 2025;41(2):150–152. doi:10.1016/j.arthro.2024.09.005
10. Sebecić B, Nikolić V, Sikirić P, et al. Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation. Bone. 1999;24(3):195-202. doi:10.1016/s8756-3282(98)00180-x
11. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. doi:10.1155/2015/648108
12. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987
13. Pickart L, Margolina A. Skin regenerative and anti-cancer actions of copper peptides. Cosmetics. 2018;5(2):29. doi:10.3390/cosmetics5020029
14. Sikiric P, Udovicic M, Barisic I, Ardalic D, Halle ZB, Zovak M, et al. BPC 157 therapy: targeting angiogenesis and nitric oxide’s cytotoxic and damaging actions, but maintaining, promoting, or recovering their essential protective functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals. 2025;18(10):1450. doi: 10.3390/ph18101450
15. Lee E, Walker C, Ayadi B. Effect of BPC-157 on symptoms in patients with interstitial cystitis: a pilot study. Altern Ther Health Med. 2024;30(10):12–17. PMID: 38041759
16. Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774-80. doi:10.1152/japplphysiol.00945.2010
17. Schaller MD, Parsons JT. pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk. Mol Cell Biol. 1995;15(5):2635–45 PMID: 7537852
18. Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377:153–159. doi:10.1007/s00441-019-03016-8
19. Sikiric P, Horvat Pavlov K, Stambolija V, Petrovic I, Vukusic D, Oroz K, et al. Stable gastric pentadecapeptide BPC 157 as therapy after surgical detachment of the quadriceps muscle from its attachments for muscle-to-bone reattachment in rats. Pharmaceutics. 2025;17(1):119. doi:10.3390/pharmaceutics17010119
20. Maquart FX, Bellon G, Pasco S, Monboisse JC. Matrikines in the regulation of extracellular matrix degradation. Biochimie. 2005;87(3–4):353–360. doi:10.1016/j.biochi.2004.10.006
21. Borkow G. Using copper to improve the well-being of the skin. Curr Chem Biol. 2014;8(2):89–102. doi:10.2174/2212796809666150227223857
22. Kang YA, Choi HR, Kim M, Park SY, Huh CH, Youn SW, et al. Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. Arch Facial Plast Surg. 2005;7(1):27–31. doi:10.1001/archfaci.7.1.27
23. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. FEBS Lett. 1988;238(2):343–346. doi:10.1016/0014-5793(88)80509-1
24. Huang T, Zhang K, Sun L, Xue X, Zhang C, Shu Z, et al. Body protective compound-157 enhances alkali-burn wound healing in vivo; promotes proliferation, migration, and angiogenesis in vitro. Drug Des Devel Ther. 2015;9:2485–2499. doi:10.2147/DDDT.S82030
25. Adnan SB, Maarof M, Fauzi MB, Fadilah NIM. Exploring the role of tripeptides in wound healing and skin regeneration: a comprehensive review. Int J Med Sci. 2025;22(16):4175-4200. doi:10.7150/ijms.118118
26. He L, Feng D, Guo H, Zhu S, Sun L, Luo Y, et al. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Front Pharmacol. 2022;13:1026182. doi:10.3389/fphar.2022.1026182
27. Hsieh MJ, Lee CH, Chueh HY, Liu CC, Lin SZ, Pang CY, et al. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Sci Rep. 2020;10:17078. doi:10.1038/s41598-020-74082-6
28. Jiang F, Wu Y, Liu Z, Hong M, Huang Y. Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests. J Cosmet Dermatol. 2023;22(9):2598–2604. doi:10.1111/jocd.15763
29. Park JR, Lee H, Kim SI, Yang SR. The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget. 2016;7(36):58405–58417. doi:10.18632/oncotarget.11168
30. Liao HJ, Chen HT, Chang CH. Peptides for targeting chondrogenic induction and cartilage regeneration in osteoarthritis. Cartilage. 2024. doi:10.1177/19476035241276406
31. Xu C, He Z, Zhong Z, Zhou Y, Hu T, Ding W, et al. Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds. Regul Toxicol Pharmacol. 2020;114:104665. doi:10.1016/j.yrtph.2020.104665
32. Tkalcevic VI, Cuzic S, Brajsa K, Mildner B, Bokulic A, Situm K, et al. Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression. Eur J Pharmacol. 2007;570:212–221. doi:10.1016/j.ejphar.2007.05.072
33. Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, et al. Stable gastric pentadecapeptide BPC 157 and standard angiogenic growth factors. Curr Pharm Des. 2018;24:1972–1989. doi:10.2174/1381612824666180116153503
34. Siméon A, Wegrowski Y, Bontemps Y, Maquart FX. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+). J Invest Dermatol. 2000;115(6):962–968. doi:10.1046/j.1523-1747.2000.00166.x
35. Lee E, Burgess K. Safety of intravenous infusion of BPC157 in humans: a pilot study. Altern Ther Health Med. 2025;31(5):20–24. PMID: 40131143
36. World Anti-Doping Agency. World Anti-Doping Code International Standard Prohibited List 2022. Montreal: WADA; 2021. Available from: https://www.wada-ama.org
37. U.S. Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. Silver Spring: FDA; 2023. Available from: https://www.fda.gov
38. Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. J Physiol Pharmacol. 2009;60(Suppl 7):191–196. PMID: 20388966
39. Jóźwiak M, Bauer M, Kamysz W, Kleczkowska P. Reply to Sikiric et al. — BPC 157 therapy. Pharmaceuticals. 2025. doi:10.3390/ph18101451
40. Cushman CJ, Ibrahim AF, Smith AD, Hernandez EJ, MacKay B, Zumwalt M. Local and systemic peptide therapies for soft tissue regeneration: a narrative review. Yale J Biol Med. 2024 Sep 30;97(3):399-413. doi: 10.59249/TKNM3388. PMID: 39351323
41. Chen H, Yang P, Xue P, Li S, Dan X, Li Y, Lei L, Fan X. Food-Derived Tripeptide-Copper Self-Healing Hydrogel for Infected Wound Healing. Biomater Res. 2025 Feb 3;29:0139. doi: 10.34133/bmr.0139. PMID: 39902373
42. Lee E, Padgett B. Intra-articular injection of BPC 157 for multiple types of knee pain. Altern Ther Health Med. 2021;27:8–13. PMID: 33609097
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Olaf Wojcieszuk, Łukasz Starczewski, Adrianna Babik, Kamila Kamińska, Matylda Będkowska-Kuśmierek, Anna Złotnik, Kinga Krzysztofik, Antoni Klamka, Paulina Kawalec, Kamil Bronikowski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 9
Number of citations: 0
